BMCM
CC icon

Bryn Mawr Capital Management’s Chemours CC Stock Holding History

Bryn Mawr Capital Management’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,581
Closed -$125K – 445
2025
Q4 		$125K Buy
10,581
+164
+2% +$2.11K 0.01% 440
2025
Q3 		$165K Hold
10,417
– – 0.01% 429
2025
Q2 		$119K Sell
10,417
-237
-2% -$2.67K 0.01% 414
2025
Q1 		$144K Sell
10,654
-10,015
-48% -$166K 0.01% 383
2024
Q4 		$349K Sell
20,669
-5,796
-22% -$113K 0.02% 328
2024
Q3 		$538K Hold
26,465
– – 0.03% 274
2024
Q2 		$597K Buy
26,465
+60
+0.2% +$1.57K 0.03% 262
2024
Q1 		$693K Sell
26,405
-800
-3% -$22.8K 0.04% 253
2023
Q4 		$858K Buy
27,205
+15,662
+136% +$425K 0.05% 228
2023
Q3 		$324K Buy
+11,543
New +$396K 0.02% 316

Other funds holding CC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
WHCM
Wolf Hill Capital Management Greenwich, Connecticut $1.2B AUM 137.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bryn Mawr Capital Management's CC Position: Q1 2026 in Review

Bryn Mawr Capital Management sold out of Chemours (CC) in Q1 2026, closing a stake of 10,581 shares — an estimated $125K sold.

Bryn Mawr Capital Management first reported a position in CC in Q3 2023 and held it in 10 quarters. The position peaked at $858K in Q4 2023. 450 funds tracked by Wall St. Rank hold CC as of Q1 2026.

  • Bryn Mawr Capital Management reported no remaining Chemours position as of Q1 2026 after selling out during the quarter.
  • Bryn Mawr Capital Management sold 10,581 Chemours shares in Q1 2026, an estimated $125K.
  • Bryn Mawr Capital Management first reported a position in Chemours in Q3 2023 and held it in 10 quarters.
  • Bryn Mawr Capital Management's Chemours position peaked at $858K in Q4 2023.
  • 450 funds tracked by Wall St. Rank held Chemours as of Q1 2026.

Based on Bryn Mawr Capital Management's 13F filing for Q1 2026, filed 4 May 2026.